Browse by Glasgow Author (original) (raw)

Number of items: 6.

2021

Horne, Gillian A. ORCID: https://orcid.org/0000-0001-9741-7352, Laird, Jennifer, Latif, Anne-Louise, Irvine, David, Wilson, Matthew ORCID: https://orcid.org/0000-0001-5423-3270 and Douglas, Kenneth(2021)The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

Latif, A.-L. et al. (2021)BRD4-mediated repression of p53 is a target for combination therapy in AML. Nature Communications, 12, 241. (doi: 10.1038/s41467-020-20378-8) (PMID:33431824) (PMCID:PMC7801601)

2020

Horne, G. et al. (2020)A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

2016

Latif, Anne-Louise and Holyoake, Tessa(2016)Lifting the differentiation embargo. Cell, 167(1), pp. 45-46. (doi: 10.1016/j.cell.2016.08.051) (PMID:27662083)

2015

Latif, Anne-Louise, Cole, John J., Monteiro Campos, Joana, Clark, Willliam, McGarry, Lynn, Brock, Claire, Newcombe, Ashley, Keeshan, Karen ORCID: https://orcid.org/0000-0001-7266-0890, Copland, Mhairi ORCID: https://orcid.org/0000-0002-7655-016X and Adams, Peter D.(2015)Dual inhibition of MDM2 and BET cooperate to eradicate acute myeloid leukemia. Blood, 126(23), p. 674. (doi: 10.1182/blood.V126.23.674.674)

2013

Sinclair, A., Latif, A.L. and Holyoake, T.L.(2013)Targeting survival pathways in chronic myeloid leukaemia stem cells. British Journal of Pharmacology, 169(8), pp. 1693-1707. (doi: 10.1111/bph.12183)

This list was generated on Tue Feb 17 03:32:13 2026 GMT.